Responding to a TB Event Bismarck, North Dakota June 24-25, 2008

Size: px
Start display at page:

Download "Responding to a TB Event Bismarck, North Dakota June 24-25, 2008"

Transcription

1 Responding to a TB Event Bismarck, North Dakota June 24-25, 2008 TB Epidemiology: Global and State Lynelle Phillips, RN, MPH June 24, 2008 TB Epidemiology Global and State Lynelle Phillips RN MPH Nurse Consultant Heartland National TB Center

2 Objectives Describe the current epidemiology of TB Globally United States Heartland Region

3

4 HIV and TB Dye, C. Global epidemiology of tuberculosis. Lancet, (9514) p Worldwide risk factors for TB Although HIV infection has clearly had a profound effect on TB spread, other risk factors have been neglected Diabetes Undernutrition Respiratory illnesses Tobacco Air pollution Dye, C. Global epidemiology of tuberculosis. Lancet, (9514) p

5 Worldwide risk factors for TB Completion of treatment DOTS directly observed therapy short course Appropriate regimen most countries do not do cultures and sensitivities Contact investigations and treatment of contacts Usually not done heavy reliance on BCG

6 Distribution of Multi-drug Resistant Tuberculosis 2006 Global Distribution of MDR TB Among New Cases Source: Zignol, Dye et al, JID 2006:194

7 Global Drug-Resistant TB: How Bad Is It? 2004 MDR TB estimates: 424,203 (4.3%) (estimate includes new and previously treated cases) 2000 MDR TB estimates: 272,906 (1.1%) (estimate includes new cases only) Estimated 43% of global MDR TB cases have had prior treatment China, India, and Russian Federation account for 62% of the MDR burden Zignol, Dye et al, JID 2006:194 Prevalence of XDR TB not known Number of MDR and XDR Cases, by Countries Submitting 1 M. tuberculosis Isolate to Participating SRLs, Ind. Nations MDR 821 XDR 53 (6%) Latin America MDR 543 XDR 32 (6%) Africa, Middle East MDR 156 XDR 1 (< 1%) E. Europe MDR 406 XDR 55 (14%) Total MDR= 3520; XDR= 347 (~ 10% of MDR)* * Country unknown, MDR= 102; XDR= 2 (2%) Rep. Korea MDR 1298 XDR 200 (15%) Asia MDR 274 XDR 4 (1%)

8 KZN Drug Resistant TB Survey Results* 1539 isolates tested 544 (35%) Cx+ 995 (65%) Cx Negative M. tuberculosis 221(41%) MDRTB 323 (59%) Susceptible 53 (10%) XDRTB (24% of MDRTB) * Moll A, Gandhi NR, Pawinski R, Lalloo U, Sturm AW, Zeller K, Andrews J, Friedland G. HIV associated Extensively Drug-Resistant TB (XDR-TB) in Rural KwaZulu-Natal (South Africa MRC Expert Consultation Sept 8, 2006)

9 Global Drug-Resistant TB: MDR/XDR TB Fuel Suboptimal TB control practices (e.g., poor DOT, infection control, and treatment without drug susceptibilities or culture) MDR TB is pre-xdr TB: poor use of second-line TB drugs in low and middle income countries HIV amplification of disease and transmission (example: KwaZulu-Natal (KZN) South Africa) Fact in 2005: only ~2% of estimated culture proven MDR TB cases are treated with 2 nd line drugs (Global Plan to Stop TB ) Have germs, will travel Migrating populations in the 1990s Compared to , four-fold increase in migration Source: Population Action International 1994

10 No. of Cases Reported TB Cases* United States, ,000 26,000 24,000 22,000 20,000 18,000 16,000 14,000 12,000 10, Year *Updated as of April 6, TB Case Rates,* United States, 2006 D.C. *Cases per 100,000. < 3.5 (year 2000 target) > 4.6 (national average)

11 Number of TB Cases in U.S.-born vs. Foreign-born Persons United States, * No. of Cases U.S.-born Foreign-born *Updated as of April 6, Percent Foreign Born TB Cases Heartland Region % foreign born AZ IL IA KS MN MO NM ND SD TX WI

12 Genotyping and epidemiology Understand Transmission Patterns Better Identify Lab Cross Contamination Learn About Unsuspected Relationships and Non-Traditional Settings for Transmission Detect and Investigate Outbreaks Sooner Focus and Prioritize Contact Investigations Evaluate Intervention Effectiveness Discern Exogenous Reinfection vs Relapse Purpose Cluster Busters To identify genotype clusters of interest Illinois, Kansas, Missouri Kansas City St. Louis Electronic match state genotyping databases New clusters Growing clusters Location-based clusters

13 Results of search for genotype MO 030 TB Case with corrections history TB case with no corrections history Secondary transmission KS MO OK AR TX Low incident states Medium incident state High incident states Cluster Analysis Results-Wisconsin Epi Links by Person and Place Household Case 11 sex partners Case 3 Case 1 Case 2 Liquor store Worksite SRO hotel In County B in County Case 10 B Restaurant Case 4 Case 7 Case 6 Case 8 Household sex partners Case 9 Source: Tanya Oemig Wisconsin TB Program Household aunt & nephew Case 5

14 Preliminary IL_003 Wichita Grace KC Rescue City Union Restart Jackson Cty Jail Local Jail Wyandotte Cty Jail

15 1998 Cases City Union Jackson Cty Jail Restart Local Jail Wyandotte Cty Jail

16

17

18 Thru 2006

19 Summary Global TB epidemiology TB on the increase expect foreign-born TB to increase in your state MDR XDR TB expected to increase be ready have a plan! Regional/state TB Considering using genotyping data and regional approach to analysis Location-based prevention strategies References Dye, C., Global epidemiology of tuberculosis. Lancet, (9514): p WHO (2008) WHO Report 2008, Global Tuberculosis Control Surveillance Planning Financing. Retrieved May 30, 2008, from WHO_2008_global_TB_report.pdf Zignol, M., et al., Global incidence of multidrug-resistant tuberculosis. Journal of Infectious Diseases, (4): p

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 5/6/2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Debra Stephens, RN, BSN, MPH April 27, 2011 Debra Stephens,

More information

Transmission of XDR TB

Transmission of XDR TB Transmission of XDR TB Neel Gandhi, MD Tugela Ferry Care & Research Collaboration (TF CARES) Albert Einstein College of Medicine November 5, 2008 TF CARES Tugela Ferry Care and Research Collaboration Background

More information

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Epidemiology Robert Petrossian July 18, 2012 Robert Petrossian has the following disclosures to make: No conflict of interests No relevant

More information

Global epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos

Global epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos Global epidemiology of drug-resistant tuberculosis Factors contributing to the epidemic of MDR/XDR-TB CHIANG Chen-Yuan MD, MPH, DrPhilos By the end of this presentation, participants would be able to describe

More information

What can be done against XDR-TB?

What can be done against XDR-TB? What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =

More information

Tuberculosis: The Big Picture And Challenge of Drug-resistance

Tuberculosis: The Big Picture And Challenge of Drug-resistance 5 th APHL National Conference on Laboratory Aspects of Tuberculosis August 11-13, 2008 San Diego, California Tuberculosis: The Big Picture And Challenge of Drug-resistance RADM Kenneth G. Castro, M.D.

More information

Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics

Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Neel R. Gandhi, MD Emory Rollins School of Public Health January 17, 2013 Medical Research Council BMJ 1948

More information

Drug-resistant Tuberculosis

Drug-resistant Tuberculosis page 1/6 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Context - Tuberculosis (TB) is an infectious disease that affects a growing number of

More information

Contact Investigations

Contact Investigations TB Nurse Case Management Albuquerque, New Mexico July 22-23, 2008 Contact Investigations Lynelle Phillips, RN, MPH July 23, 2008 Contact Investigations Lynelle Phillips, RN MPH Heartland National TB Center

More information

Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010

Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010 Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Mary Long, MPSH; Heartland Phillip Lindsey, MD; OK State

More information

California s Experiences Using Tuberculosis Whole Genome Sequencing

California s Experiences Using Tuberculosis Whole Genome Sequencing California s Experiences Using Tuberculosis Whole Genome Sequencing Martin Cilnis MS, MPH Epidemiologist California Department of Public Health, TB Control Branch, Outbreak Prevention and Control Section

More information

Annual Tuberculosis Report Oregon 2007

Annual Tuberculosis Report Oregon 2007 Annual Tuberculosis Report Oregon 7 Oregon Department of Human Services Public Health Division TB Program April 8 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-7.. page

More information

ANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012

ANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012 ANNUAL TUBERCULOSIS REPORT OREGON 211 Oregon Health Authority Public Health Division TB Program November 212 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-211... page

More information

California s Experiences Using Tuberculosis Whole Genome Sequencing

California s Experiences Using Tuberculosis Whole Genome Sequencing California s Experiences Using Tuberculosis Whole Genome Sequencing Martin Cilnis MS, MPH Epidemiologist California Department of Public Health, TB Control Branch, Outbreak Prevention and Control Section

More information

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area Rapid communications Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area C Ködmön (csaba.kodmon@ecdc.europa.eu)

More information

Transmission of DS-TB and MDR-TB. C. Robert Horsburgh, Jr. Boston University School of Public Health

Transmission of DS-TB and MDR-TB. C. Robert Horsburgh, Jr. Boston University School of Public Health Transmission of DS-TB and MDR-TB C. Robert Horsburgh, Jr. Boston University School of Public Health Outline Epidemiologic factors in transmission Ability of the transmitter to transmit Susceptibility of

More information

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition

More information

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people

More information

Global, National, Regional

Global, National, Regional Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology

More information

Epidemiological Methods in TB

Epidemiological Methods in TB Responding to a TB Event San Antonio, Texas April 29-May 1, 28 Epidemiological Methods in TB Lynelle Phillips, RN, MPH April 29, 28 Epidemiological Methods in TB Lynelle Phillips, RN MPH Heartland National

More information

Global, National, Regional

Global, National, Regional Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology

More information

MULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic

MULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin

More information

TB Program Management San Antonio, Texas November 5-7, 2008

TB Program Management San Antonio, Texas November 5-7, 2008 TB Program Management San Antonio, Texas November 5-7, 2008 Infection Control Lynelle Phillips, RN, MPH November 7, 2008 Infection Control Lynelle Phillips, RN MPH Nurse Consultant Heartland National TB

More information

HIV and Drug-Resistant TB Reflections from rural Tugela Ferry

HIV and Drug-Resistant TB Reflections from rural Tugela Ferry HIV and Drug-Resistant TB Reflections from rural Tugela Ferry Neel R. Gandhi, MD Tugela Ferry Care & Research Collaboration (TF CARES) Albert Einstein College of Medicine 3 March 2010 HIV & Drug-Resistant

More information

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Chapter 1 Overview of Tuberculosis Epidemiology in the United States Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States... 3 TB Disease Trends in the United

More information

Controlling TB in the era of HIV

Controlling TB in the era of HIV Controlling TB in the era of HIV Christy Hanson, PhD, MPH TB Research Advisor Amy Bloom, MD TB/HIV Advisor TB Incidence rates highest in Africa Estimated new TB cases (all forms) per 100 000 population

More information

The epidemiology of tuberculosis

The epidemiology of tuberculosis The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications

More information

Tuberculosis Surveillance

Tuberculosis Surveillance Tuberculosis Surveillance Cambridge Surveillance Report on Active Tuberculosis, 26-21 Division of Epidemiology and Data Services April 211 Photo of Gram-positive Mycobacterium tuberculosis bacteria. Source:

More information

TB in California: Costs, Transmission, and Selecting from the Latent Pool

TB in California: Costs, Transmission, and Selecting from the Latent Pool TB in California: Costs, Transmission, and Selecting from the Latent Pool Pennan Barry, MD, MPH Tuberculosis Control Branch California Department of Public Health California Tuberculosis Controller s Association

More information

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Feedback Poll In my opinion, the recent media coverage of

More information

2018 Perinatal Hepatitis B Summit. Eva Hansson, RN, MSN Perinatal Hepatitis B Prevention Coordinator

2018 Perinatal Hepatitis B Summit. Eva Hansson, RN, MSN Perinatal Hepatitis B Prevention Coordinator 2018 Perinatal Hepatitis B Summit Eva Hansson, RN, MSN Perinatal Hepatitis B Prevention Coordinator Overview of Summit Summary of perinatal Hepatitis B in the US & Texas ACIP Hepatitis B Prevention recommendations

More information

The emerging threat of multidrug resistant TB: Global and local challenges and solutions

The emerging threat of multidrug resistant TB: Global and local challenges and solutions Summary of IOM-ASSAf Workshop on: The emerging threat of multidrug resistant TB: Global and local challenges and solutions Salim S. Abdool Karim Pretoria - March, 2010 Why this workshop? Why is it on MDR

More information

TB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research

TB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

TUBERCULOSIS. Presented By: Public Health Madison & Dane County TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any

More information

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine XDR and MDR TB Urgent Research Priorities Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine The Year of MDR XDR TB CDC, WHO report on global XDR TB XDR TB defined Global distribution

More information

511,000 (57% new cases) ~50,000 ~30,000

511,000 (57% new cases) ~50,000 ~30,000 Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27

More information

Global MDR-TB Update GIDC. Paul Nunn, MA, FRCP(UK) Director, Global Infectious Disease Consulting London, UK

Global MDR-TB Update GIDC. Paul Nunn, MA, FRCP(UK) Director, Global Infectious Disease Consulting London, UK Global MDR-TB Update Paul Nunn, MA, FRCP(UK) Director, Global Infectious Disease Consulting London, UK Acknowledgements Matteo Zignol Mario Raviglione All the WHO staff in drug resistance surveillance

More information

Molecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis

Molecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis Molecular Epidemiology of Tuberculosis Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis Overview TB transmission and pathogenesis Genotyping methods Genotyping for clinical management

More information

TB Outbreak Investigation in Fishery Workers, Maryland. Cassandra Althauser PHASE Internship Maryland Department of Health and Human Hygiene

TB Outbreak Investigation in Fishery Workers, Maryland. Cassandra Althauser PHASE Internship Maryland Department of Health and Human Hygiene TB Outbreak Investigation in Fishery Workers, Maryland Cassandra Althauser PHASE Internship Maryland Department of Health and Human Hygiene Airborne Transmission Tuberculosis Small droplet nuclei (

More information

A National and Statewide Perspective on the Opioid Crisis

A National and Statewide Perspective on the Opioid Crisis Insert CIO Name Here A National and Statewide Perspective on the Opioid Crisis Amy Peeples, MPA Deputy Director, National Center for Injury Prevention and Control Centers for Disease Control and Prevention

More information

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps Matteo Zignol STOP TB Department World Health Organization TB surveillance and

More information

Diagnosis of drug resistant TB

Diagnosis of drug resistant TB Diagnosis of drug resistant TB Megan Murray, MD, ScD Harvard School of Public Health Brigham and Women s Hospital Harvard Medical School Broad Institute Global burden of TB 9 million new cases year 2 million

More information

Tuberculosis Epidemiology

Tuberculosis Epidemiology Tuberculosis Epidemiology TB CLINICAL INTENSIVE COURSE Curry International Tuberculosis Center October 18, 2017 Varsha Hampole, MPH Tuberculosis Control Branch California Department Of Public Health Outline

More information

TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks

TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks 1 TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks 2 Page 1 4 NHS Lothian Infection Prevention and Control Study Day On

More information

The Impact of Effective Treatment on TB Transmission FAST: A re-focused, intensified, administrative approach to institutional TB transmission control

The Impact of Effective Treatment on TB Transmission FAST: A re-focused, intensified, administrative approach to institutional TB transmission control The Impact of Effective Treatment on Transmission FAST: A re-focused, intensified, administrative approach to institutional transmission control Edward A. Nardell, MD Professor of Medicine Brigham & Women

More information

Why can t we eliminate tuberculosis?

Why can t we eliminate tuberculosis? Why can t we eliminate tuberculosis? Neil W. Schluger, M.D. Professor of Medicine, Epidemiology and Environmental Health Sciences Columbia University Chief Scientific Officer World Lung Foundation Current

More information

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words

More information

DRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION

DRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION JOURNAL OF PREVENTIVE MEDICINE 2008; 16(3-4): 3-9 Inviting Editorial DRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION Harshad Thakur Centre for Health Policy, Planning and Management,

More information

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges David Karol, MD, MA Bureau of Prisons, FMC Butner Duke University Medical Center June 26, 2013 No Disclosures

More information

2016 Annual Tuberculosis Report For Fresno County

2016 Annual Tuberculosis Report For Fresno County 206 Annual Tuberculosis Report For Fresno County Cases Rate per 00,000 people 206 Tuberculosis Annual Report Fresno County Department of Public Health (FCDPH) Tuberculosis Control Program Tuberculosis

More information

TB Intensive San Antonio, Texas

TB Intensive San Antonio, Texas TB Intensive San Antonio, Texas May 6 9, 2014 Ethical Management of Patients with Complicated TB Disease Adriana Vasquez, MD May 9, 2014 Adriana Vasquez, MD has the following disclosures to make: No conflict

More information

Turning Off the Spigot Reducing Nosocomial Drug Resistant TB. Edward A. Nardell, MD Harvard Medical School/PIH Brigham & Women s Hospital

Turning Off the Spigot Reducing Nosocomial Drug Resistant TB. Edward A. Nardell, MD Harvard Medical School/PIH Brigham & Women s Hospital Turning Off the Spigot Reducing Nosocomial Drug Resistant Transmission Edward A. Nardell, MD Harvard Medical School/PIH Brigham & Women s Hospital is an airborne infection Every case of MDR/XDR prevented

More information

Multidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017

Multidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017 Multidrug-/ rifampicinresistant TB (MDR/RR-TB): Update 2017 The global TB situation (1) Estimated incidence, 2016 Estimated number of deaths, 2016 All forms of TB HIV-associated TB Multidrug- / rifampicin-resistant

More information

Addressing TB in a High HIV Prevalence Setting in Rural South Africa: the 3Is

Addressing TB in a High HIV Prevalence Setting in Rural South Africa: the 3Is Addressing TB in a High HIV Prevalence Setting in Rural South Africa: the 3Is Yale AIDS Program Section of Infectious Diseases Yale University School of Medicine Sheela Shenoi MD MPH September 20, 2012

More information

Helping TB patients quit smoking: the potential impact, WHO recommendations and country experience

Helping TB patients quit smoking: the potential impact, WHO recommendations and country experience Helping TB patients quit smoking: the potential impact, WHO recommendations and country experience Dr Dongbo Fu Prevention of Noncommunicable Diseases World Health Organization 1 Outline Why national TB

More information

Evolution of XDR-TB. A. Willem Sturm Interim Director K-RITH Nelson R Mandela School of Medicine University of KwaZulu-Natal

Evolution of XDR-TB. A. Willem Sturm Interim Director K-RITH Nelson R Mandela School of Medicine University of KwaZulu-Natal Evolution of XDR-TB in KwaZulu-Natal A. Willem Sturm Interim Director K-RITH Nelson R Mandela School of Medicine University of KwaZulu-Natal Drug resistance among culture positive TB cases by South African

More information

TB trends and TB genotyping

TB trends and TB genotyping Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures

More information

The WHO END-TB Strategy

The WHO END-TB Strategy ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who

More information

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America Mike Segar / Reuters Executive Summary Context On 26 September 2018, the United Nations

More information

Drug-resistant Tuberculosis

Drug-resistant Tuberculosis page 1/15 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Level 2 - Details on Drug-resistant Tuberculosis 1. What is tuberculosis and why is it

More information

TB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology

TB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology TB EPIDEMIOLOGY TB Clinical Intensive Course Curry International Tuberculosis Center September 30, 2015 Varsha Nimbal, MPH Tuberculosis Control Branch California Department of Public Health 1 Outline TB

More information

Global Burden of Respiratory Disease Lessons from Afar Scott Barnhart, MD, MPH June 18, 2010

Global Burden of Respiratory Disease Lessons from Afar Scott Barnhart, MD, MPH June 18, 2010 Global Burden of Respiratory Disease Lessons from Afar Scott Barnhart, MD, MPH June 18, 2010 Scott Barnhart, MD, MPH June 18, 2010 Three Goals An Overview of the global burden of respiratory disease relative

More information

Drug Resistant Tuberculosis Biology, Epidemiology and Control Dr. Christopher Dye

Drug Resistant Tuberculosis Biology, Epidemiology and Control Dr. Christopher Dye Director of Health Information World Health Organization Geneva 1 1. Why TB patients are treated with drugs 2 Natural history and control of TB Fast 5/1 Slow 5/1 Uninfected Latent Active 1 1 infection/case

More information

Short Course Treatment for MDR TB

Short Course Treatment for MDR TB Objectives Short Course Treatment for MDR TB Barbara J Seaworth M.D. Medical Director Heartland National TB Center Professor of Medicine, University of Texas Health Northeast Participants will utilize

More information

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium

More information

Children as Sentinels for Transmission and Policy Response Mercedes Becerra, ScD

Children as Sentinels for Transmission and Policy Response Mercedes Becerra, ScD Children as Sentinels for Transmission and Policy Response Mercedes Becerra, ScD Associate Professor, Harvard Medical School, Boston, MA, USA TB Specialist, Partners In Health, Boston, MA, USA Overview

More information

Please evaluate this material by clicking here:

Please evaluate this material by clicking here: EPI Case Study 3: Cross-Sectional, Case-Control, and Cohort Studies Identification of TB Risk Time to Complete Exercise: 60 minutes LEARNING OBJECTIVES At the completion of this module, participants should

More information

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever

More information

Drug resistance TB in People Living with HIV: research questions and priorities.

Drug resistance TB in People Living with HIV: research questions and priorities. Drug resistance TB in People Living with HIV: research questions and priorities. Haileyesus Getahun, MD, PhD. Stop TB Department World Health Organisation Geneva, Switzerland Outline of presentation Definition

More information

International Journal of Sciences: Basic and Applied Research (IJSBAR) ISSN (Print & Online)

International Journal of Sciences: Basic and Applied Research (IJSBAR) ISSN (Print & Online) International Journal of Sciences: Basic and Applied Research (IJSBAR) ISSN 2307-4531 (Print & Online) http://gssrr.org/index.php?journal=journalofbasicandapplied ---------------------------------------------------------------------------------------------------------------------------

More information

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases

More information

The Emerging Threat of Multidrug-Resistant Tuberculosis: Global and Local Challenges and Solutions

The Emerging Threat of Multidrug-Resistant Tuberculosis: Global and Local Challenges and Solutions The Emerging Threat of Multidrug-Resistant Tuberculosis: March 3-4, 2010 Roode Vallei Country Lodge With the development of antibiotics in the twentieth century, tuberculosis gradually lost its central

More information

2015 Annual Report Tuberculosis in Fresno County. Department of Public Health

2015 Annual Report Tuberculosis in Fresno County. Department of Public Health 215 Annual Report Tuberculosis in Fresno County Department of Public Health www.fcdph.org Number of Cases Rate per 1, Population 215 Tuberculosis Annual Report Fresno County Department of Public Health

More information

A CASE CONTROL STUDY ON CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES IN TUBERCULOSIS PATIENTS WITH DIABETES IN PALAKKAD DISTRICT

A CASE CONTROL STUDY ON CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES IN TUBERCULOSIS PATIENTS WITH DIABETES IN PALAKKAD DISTRICT INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article A CASE CONTROL STUDY ON CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES IN TUBERCULOSIS PATIENTS

More information

Tuberculosis in Alameda County, 2009

Tuberculosis in Alameda County, 2009 Tuberculosis in Alameda County, 29 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a communicable disease caused by the bacteria Mycobacterium tuberculosis. TB is spread

More information

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO TB in the SEA Region Review Plans and Progress Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO The SEA Region: 25% of the world s people, but >33% of TB patients Eastern M editerranean Region 5%

More information

State of the State in TB Control

State of the State in TB Control State of the State in TB Control Jason Stout, MD, MHS Wake County TB Medical Consultant NC TB Medical Director Division of Infectious Diseases, Duke University Medical Center Disclosures-Funding NIH (grant)

More information

Overview of the TB epidemic globally and in India

Overview of the TB epidemic globally and in India Overview of the TB epidemic globally and in India Dr Soumya Swaminathan Deputy Director General for Programmes 5 th GLOBAL FORUM ON TB VACCINES PARTNERING FOR PROGRESS AND INNOVATION February 20, 2018

More information

Contact Investigation San Antonio, Texas January 14-15, 2013

Contact Investigation San Antonio, Texas January 14-15, 2013 Contact Investigation San Antonio, Texas January 14-15, 2013 Detecting and Handling a TB Outbreak Jessica Quintero, BAAS January 15, 2013 Jessica Quintero, BAAS has the following disclosures to make: No

More information

Tuberculosis Screening and Targeted Testing of College and University Students: Developing a Best Practice Approach:

Tuberculosis Screening and Targeted Testing of College and University Students: Developing a Best Practice Approach: Tuberculosis Screening and Targeted Testing of College and University Students: Developing a Best Practice Approach: Lori A. Soos MA, BSN, RN, Niagara University Deborah Penoyer, MS, RN, SUNY Geneseo Learning

More information

Guidelines for TB contact tracing in Pacific Island countries and territories

Guidelines for TB contact tracing in Pacific Island countries and territories Guidelines for TB contact tracing in Pacific Island countries and territories Background Tuberculosis (TB) continues to be a public health issue of major significance around the world. The World Health

More information

TB Outbreak in a Homeless Shelter

TB Outbreak in a Homeless Shelter TB Outbreak in a Homeless Shelter Objectives Epidemiology of Outbreak Population Health Interventions Population Health Goals 2007 One active case identified Less than compliant Prolonged recovery Contact

More information

NIAID Research Agenda Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

NIAID Research Agenda Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis NIAID Research Agenda Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis NIAID Tuberculosis Working Group June 6, 2007 NIAID MDR/XDR TB Research Agenda June 6, 2007 Preface The National Institute

More information

MDR-TB and HIV co-infection in Eastern Europe. Francis Drobniewski MBBS PhD Professor of Global Health and Tuberculosis

MDR-TB and HIV co-infection in Eastern Europe. Francis Drobniewski MBBS PhD Professor of Global Health and Tuberculosis MDR-TB and HIV co-infection in Eastern Europe Francis Drobniewski MBBS PhD Professor of Global Health and Tuberculosis f.drobniewski@imperial.ac.uk Conflict of interest In the last year I have been a consultant

More information

Arizona Annual Tuberculosis Surveillance Report

Arizona Annual Tuberculosis Surveillance Report Arizona Annual Tuberculosis Surveillance Report 2014 Table of Contents I. Executive Summary 1 II. Case Rates 3 III. Cases and Case Rates by Race and Ethnicity 4 IV. Cases by Gender 4 V. Cases and Case

More information

GLOBAL STATISTICS FACT SHEET 2015

GLOBAL STATISTICS FACT SHEET 2015 FACT SHEET 2015 GLOBAL STATISTICS 15.8 people accessing antiretroviral therapy (June 2015) 36.9 [34.3 41.4 ] people globally were living with HIV (end 2014) 2 [1.9 2.2 ] people became newly infected with

More information

SOUTH AFRICA S TB BURDEN - OVERVIEW

SOUTH AFRICA S TB BURDEN - OVERVIEW SOUTH AFRICA S TB BURDEN - OVERVIEW Dr Aaron Motsoaledi, MP: Chairperson of the Board, Stop TB Partnership Minister of Health, South Africa 31 January 2014, Cape Town South Africa s TB Burden Global TB

More information

DNA FINGERPRINTING. Barry N. Kreiswirth, PhD Director, PHRI TB Center

DNA FINGERPRINTING. Barry N. Kreiswirth, PhD Director, PHRI TB Center DNA FINGERPRINTING Barry N. Kreiswirth, PhD Director, PHRI TB Center Molecular Epidemiology Local Epidemiology Are M. tuberculosis isolates recovered from localized cases of disease the same or different

More information

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1

More information

Annual Epidemiological Report

Annual Epidemiological Report Annual Epidemiological Report March 2018 National TB surveillance in Ireland, 2017 Key Facts 321 TB cases were notified to HPSC corresponding to a crude incidence rate (CIR) of 6.7 HSE East reported the

More information

Multidrug-resistant Tuberculosis - World, Europe, Switzerland

Multidrug-resistant Tuberculosis - World, Europe, Switzerland Multidrug-resistant Tuberculosis - World, Europe, Switzerland Magglingen March 23, 2017 peter.helbling@bag.admin.ch Topics Definitions Epidemiology of TB and MDR-TB worldwide Treatment outcome results

More information

Therapeutic Drug Monitoring for Improving TB Treatment Outcomes: A Concept for a Randomized Clinical Trial before Clinical Implementation

Therapeutic Drug Monitoring for Improving TB Treatment Outcomes: A Concept for a Randomized Clinical Trial before Clinical Implementation Therapeutic Drug Monitoring for Improving TB Treatment Outcomes: A Concept for a Randomized Clinical Trial before Clinical Implementation Randall Reves, MD, MSc TB Consultant Professor of Medicine and

More information

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1

More information

2014 Annual Report Tuberculosis in Fresno County. Department of Public Health

2014 Annual Report Tuberculosis in Fresno County. Department of Public Health 214 Annual Report Tuberculosis in Fresno County Department of Public Health www.fcdph.org Tuberculosis (TB) is a common communicable disease caused by the bacterium Mycobacterium tuberculosis and occasionally

More information

Outline. Tuberculosis (TB) Medical Evaluation for TB 5/5/2014. Chest Radiograph with Lower Lobe Cavity

Outline. Tuberculosis (TB) Medical Evaluation for TB 5/5/2014. Chest Radiograph with Lower Lobe Cavity Jean Beinemann RN, Terri Boxrucker RN, and LT Dee Dee Downie MPH Outline The disease The outbreak The response The conclusions May 18, 2014 Wisconsin Public Health Association Annual Meeting Tuberculosis

More information

The Epidemiology of Tuberculosis in Minnesota,

The Epidemiology of Tuberculosis in Minnesota, The Epidemiology of Tuberculosis in Minnesota, 2011 2015 Minnesota Department of Health Tuberculosis Prevention and Control Program (651) 201-5414 Tuberculosis surveillance data for Minnesota are available

More information

in control group 7, , , ,

in control group 7, , , , Q1 Rotavirus is a major cause of severe gastroenteritis among young children. Each year, rotavirus causes >500,000 deaths worldwide among infants and very young children, with 90% of these deaths occurring

More information

Updates: Candida Epidemiology and Candida auris

Updates: Candida Epidemiology and Candida auris National Center for Emerging and Zoonotic Infectious Diseases Updates: Candida Epidemiology and Candida auris Tom Chiller MD MPHTM Chief, Mycotic Diseases Branch My usual Disclosure! 1 Candidemia surveillance

More information

GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY

GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY 2018 Context On 26 September 2018, the United Nations (UN) will hold its first highlevel meeting on tuberculosis (TB), at its headquarters in New York. The

More information